Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

S Leucht, A Cipriani, L Spineli, D Mavridis, D Örey… - The Lancet, 2013 - thelancet.com
Background The question of which antipsychotic drug should be preferred for the treatment
of schizophrenia is controversial, and conventional pairwise meta-analyses cannot provide …

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis

S Leucht, D Örey, F Richter, M Samara, W Kissling… - Lancet, 2013 - ora.ox.ac.uk
Background: The question of which antipsychotic drug should be preferred for the treatment
of schizophrenia is controversial, and conventional pairwise meta-analyses cannot provide …

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.

S Leucht, A Cipriani, L Spineli, D Mavridis… - Lancet (London …, 2013 - europepmc.org
Background The question of which antipsychotic drug should be preferred for the treatment
of schizophrenia is controversial, and conventional pairwise meta-analyses cannot provide …

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

S Leucht, A Cipriani, L Spineli, D Mavridis, D Orey… - THE LANCET, 2013 - iris.univr.it
BACKGROUND: The question of which antipsychotic drug should be preferred for the
treatment of schizophrenia is controversial, and conventional pairwise meta-analyses …

[引用][C] Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

S Leucht, A Cipriani, L Spineli, D Mavridis, D Örey… - The Lancet, 2013 - cir.nii.ac.jp
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments
meta-analysis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.

S Leucht, A Cipriani, L Spineli, D Mavridis, D Orey… - 2013 - mediatum.ub.tum.de
The question of which antipsychotic drug should be preferred for the treatment of
schizophrenia is controversial, and conventional pairwise meta-analyses cannot provide a …

[HTML][HTML] Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

S Leucht, A Cipriani, L Spineli, D Mavridis… - Database of Abstracts …, 2013 - ncbi.nlm.nih.gov
The authors concluded that antipsychotic drugs differed in many properties and could not be
categorised into first-and second-generation groupings; the suggested hierarchies should …

[PDF][PDF] Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

S Leucht, A Cipriani, L Spineli, D Mavridis, D Örey… - 2013 - Citeseer
Background The question of which antipsychotic drug should be preferred for the treatment
of schizophrenia is controversial, and conventional pairwise meta-analyses cannot provide …

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

S Leucht, A Cipriani, L Spineli, D Mavridis, D Örey… - The Lancet, 2013 - Elsevier
Background The question of which antipsychotic drug should be preferred for the treatment
of schizophrenia is controversial, and conventional pairwise meta-analyses cannot provide …

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

S Leucht, A Cipriani, L Spineli, D Mavridis, D Örey… - The Lancet, 2013 - thelancet.com
Background The question of which antipsychotic drug should be preferred for the treatment
of schizophrenia is controversial, and conventional pairwise meta-analyses cannot provide …